mRNA

Quantoom, Univercells and Fiocruz collaborate on RNA vaccines

Quantoom Biosciences and Univercells inked a deal with the Oswaldo Cruz Foundation (Fiocruz) to expand production of RNA-based vaccines and therapies.

Joseph Keenan Dec 2, 2024 11:50am

GSK takes mRNA patent fight to Moderna

Oct 15, 2024 6:34pm

Moderna unveils free Coursera class on mRNA medicines

Aug 14, 2024 7:00am

Penn sues BioNTech over Comirnaty royalties

Aug 7, 2024 7:30am

BioNTech posts €808M loss as it grapples with seasonal vaccines

Aug 5, 2024 10:56am

Agilent will pay $925M to acquire specialty CDMO Biovectra

Jul 22, 2024 11:01am